- Home
- INTS vs FTFT Comparison
INTS vs FTFT Comparison
Compare INTS & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- FTFT
- Stock Information
- Founded
- INTS 2012
- FTFT N/A
- Country
- INTS United States
- FTFT United States
- Employees
- INTS N/A
- FTFT N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- FTFT Business Services
- Sector
- INTS Health Care
- FTFT Consumer Discretionary
- Exchange
- INTS Nasdaq
- FTFT Nasdaq
- Market Cap
- INTS 10.9M
- FTFT 11.0M
- IPO Year
- INTS 2023
- FTFT N/A
- Fundamental
- Price
- INTS $0.24
- FTFT $2.19
- Analyst Decision
- INTS Strong Buy
- FTFT
- Analyst Count
- INTS 4
- FTFT 0
- Target Price
- INTS $4.50
- FTFT N/A
- AVG Volume (30 Days)
- INTS 3.9M
- FTFT 416.1K
- Earning Date
- INTS 11-12-2025
- FTFT 11-18-2025
- Dividend Yield
- INTS N/A
- FTFT N/A
- EPS Growth
- INTS N/A
- FTFT N/A
- EPS
- INTS N/A
- FTFT N/A
- Revenue
- INTS N/A
- FTFT $2,368,206.00
- Revenue This Year
- INTS N/A
- FTFT N/A
- Revenue Next Year
- INTS N/A
- FTFT N/A
- P/E Ratio
- INTS N/A
- FTFT N/A
- Revenue Growth
- INTS N/A
- FTFT N/A
- 52 Week Low
- INTS $0.19
- FTFT $1.01
- 52 Week High
- INTS $4.18
- FTFT $5.70
- Technical
- Relative Strength Index (RSI)
- INTS 36.68
- FTFT 48.51
- Support Level
- INTS $0.22
- FTFT $1.82
- Resistance Level
- INTS $0.25
- FTFT $3.88
- Average True Range (ATR)
- INTS 0.02
- FTFT 0.46
- MACD
- INTS -0.00
- FTFT -0.03
- Stochastic Oscillator
- INTS 29.27
- FTFT 17.96
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.